|
|
|
|
|
|
TABLE OF CONTENTS
|
August 2007 ASCO to ask U.S. Medicare to revise rule on anemia drugs August 30, 2007 WASHINGTON (Reuters) - U.S. cancer doctors on Thursday plan to ratchet up pressure on the federal Medicare agency to reverse new limits on use of anemia drugs made by Amgen Inc. and Johnson & Johnson. Gabapentin improves opioid treatment of neuropathic cancer pain August 30, 2007 NEW YORK (Reuters Health) - The combination of gabapentin and an opioid provides better relief of neuropathic pain in cancer patients than opioid monotherapy, results of a study published in the August issue of the Journal of Pain and Symptom Management indicate. Hyperglycemia prevalent, associated with high mortality in AML August 30, 2007 NEW YORK (Reuters Health) - Hyperglycemia increases the incidence of in-hospital death by nearly 40% in patients with acute myeloid leukemia (AML). The increase in mortality is seen even in patients with mild hyperglycemia, according to results of a retrospective study. US FDA proposes sunscreen rule, cancer warning Declines in physical health noted in adult survivors of childhood cancer Cancer survival in US increasing for many cancer types August 20, 2007 WASHINGTON (Reuters Life!) - A therapeutic vaccine designed for breast cancer appears to be safe in women with advanced disease and shows signs of actually slowing down tumor growth, U.S. researchers reported on Friday. August 17, 2007 NEW YORK (Reuters Health) - Treatment of patients with locally advanced non-small cell lung cancer (NSCLC) with concomitant chemotherapy and radiation may be the most successful way to extend survival, according to researchers at the University of Amsterdam. August 17, 2007 NEW YORK (Reuters Health) - Physician estimates of survival in terminally ill cancer patients are quite imprecise, especially for patients near death, according to findings published in the August 1st issue of the Journal of Clinical Oncology. August 16, 2007 NEW YORK (Reuters Health) - Radiofrequency ablation is a reasonable alternative to partial nephrectomy for the treatment of T1a renal tumors, according to findings published in the August issue of BJU International. August 14, 2007 NEW YORK (Reuters Health) - Human papillomavirus (HPV) vaccine does not accelerate clearance of HPV infections, investigators report in the Journal of the American Medical Association for August 13. August 13, 2007 NEW YORK (Reuters Health) - Vaccination of colorectal cancer patients with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax, Oxford BioMedica), given along with chemotherapy, induces "potent" immune responses, UK researchers report in the August 1st issue of Clinical Cancer Research. August 10, 2007 NEW YORK (Reuters Health) - The combination of sorafenib and interferon alfa-2b has substantial activity in patients with metastatic renal cell cancer, according to a phase II trial reported in the August 1st issue of the Journal of Clinical Oncology. August 10, 2007 NEW YORK (Reuters Health) - The increasing use of intravesical therapies for stage T1 bladder cancer has coincided with decreasing survival after cystectomy, according to New York-based researchers. Zoledronic acid reduces bone damage in prostate cancer patients August 9, 2007 NEW YORK (Reuters Health) - Zoledronic acid given every 3 months reduces bone density loss and bone turnover in men with hormone-sensitive prostate cancer, according to a new report. August 9, 2007 NW YORK (Reuters Health) - The severe cardiotoxicity that can limit the use of the antitumor agent, doxorubicin, appears to be minimized with antagonists to the cannabinoid-1 (CB-1) receptor, according to the results of in vivo and in vitro research. August 9, 2007 NEW YORK (Reuters Health) - Conservative surgical management of small-volume stage IB1 cervical cancer provides excellent outcomes, according to findings published in the August issue of BJOG: An International Journal of Obstetrics and Gynaecology. August 9, 2007 NEW YORK (Reuters Health) - Early-stage breast cancer patients treated with left-sided radiation as a component of breast conservation have an increased risk of late, radiation-associated coronary damage, according to researchers. August 9, 2007 NEW YORK (Reuters Health) - The findings from a new study support a role for MRI in detecting ductal carcinoma in situ (DCIS), particularly disease with a high nuclear grade. August 8, 2007 NEW YORK (Reuters Health) - Long-term survivors of vaginal and cervical cancer are as likely as other women to be sexually active, but they have a lot more sex-related problems and these are often not addressed by their doctors, researchers report. Avastin improves survival in metastatic cancer, but ups risk of arterial embolismAugust 7, 2007 NEW YORK (Reuters Health) - When added to conventional chemotherapy for treatment of metastatic cancer, bevacizumab (Avastin; Genentech, Inc.) significantly prolongs survival. But results of a meta-analysis suggest that bevacizumab slightly increases the risk of arterial thromboembolism. Surveillance mammography reduces mortality in older breast cancer survivors August 3, 2007 NEW YORK (Reuters Health) - Mammographic surveillance is associated with a reduction in breast cancer mortality among older women who have survived the malignancy once, according to a report in the Journal of Clinical Oncology for July 20. Laparoscopic-assisted surgery provides good long-term outcomes in colon cancer August 2, 2007 NEW YORK (Reuters Health) - As late as 3 years after surgery, the results of laparoscopic-assisted resection of colorectal cancer are as good as results with open surgery, according to a report in the July 20th issue of the Journal of Clinical Oncology. Minimally invasive therapy destroys kidney cancer August 2, 2007 NEW YORK (Reuters Health) - Patients with kidney cancer who are poor candidates for surgery can be treated using a less invasive alternative, according to a study conducted at Wake Forest University in Winston-Salem, North Carolina. Chemo added to radiation improves survival in elderly lung cancer patients August 1, 2007 NEW YORK (Reuters Health) - Patients aged more than 65 years with non-small cell lung cancer (NSCLC) live longer when treated with combined-modality therapy, but at the cost of greater toxicity, researchers report. Copyright 2008 Reuters. Click for Restrictions.
|
